Publicacións en colaboración con investigadores/as de Centro de Investigación Médica Aplicada (26)

2023

  1. Generation of an induced pluripotent stem cell line (ESi107-A) from a transthyretin amyloid cardiomyopathy (ATTR-CM) patient carrying a p.Ser43Asn mutation in the TTR gene

    Stem Cell Research, Vol. 71

2022

  1. A Fibrosis Biomarker Early Predicts Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy

    Cancers, Vol. 14, Núm. 12

  2. Fabrication of human myocardium using multidimensional modelling of engineered tissues

    Biofabrication, Vol. 14, Núm. 4

2021

  1. Preclinical evaluation of the safety and immunological action of allogeneic ADSC-collagen scaffolds in the treatment of chronic ischemic cardiomyopathy

    Pharmaceutics, Vol. 13, Núm. 8

2020

  1. Cells, Materials, and Fabrication Processes for Cardiac Tissue Engineering

    Frontiers in Bioengineering and Biotechnology, Vol. 8

  2. Does chronic kidney disease facilitate malignant myocardial fibrosis in heart failure with preserved ejection fraction of hypertensive origin?

    Journal of Clinical Medicine, Vol. 9, Núm. 2

  3. Single-Cell RNA Sequencing Analysis Reveals a Crucial Role for CTHRC1 (Collagen Triple Helix Repeat Containing 1) Cardiac Fibroblasts After Myocardial Infarction

    Circulation, Vol. 142, Núm. 19, pp. 1831-1847

2017

  1. Non-invasive in vivo imaging of cardiac stem/progenitor cell biodistribution and retention after intracoronary and intramyocardial delivery in a swine model of chronic ischemia reperfusion injury

    Journal of Translational Medicine, Vol. 15, Núm. 1

2016

  1. Catheter-based intramyocardial injection of FGF1 or NRG1-loaded MPs improves cardiac function in a preclinical model of ischemia-reperfusion

    Scientific Reports, Vol. 6

2015

  1. Neuregulin-1β induces mature ventricular cardiac differentiation from induced pluripotent stem cells contributing to cardiac tissue repair

    Stem Cells and Development, Vol. 24, Núm. 4, pp. 484-496

2014

  1. Controlled delivery of fibroblast growth factor-1 and neuregulin-1 from biodegradable microparticles promotes cardiac repair in a rat myocardial infarction model through activation of endogenous regeneration

    Journal of Controlled Release, Vol. 173, Núm. 1, pp. 132-139

  2. Epicardial delivery of collagen patches with adipose-derived stem cells in rat and minipig models of chronic myocardial infarction

    Biomaterials, Vol. 35, Núm. 1, pp. 143-151

2013

  1. Cardiac regeneration with stem cells

    Regenerative Medicine and Cell Therapy (Humana Press Inc.), pp. 65-112

  2. Safety and liver transduction efficacy of raav5-cohpbgd in nonhuman primates: A potential therapy for acute intermittent porphyria

    Human Gene Therapy, Vol. 24, Núm. 12, pp. 1007-1017

2012

  1. Adipose stromal vascular fraction improves cardiac function in chronic myocardial infarction through differentiation and paracrine activity

    Cell Transplantation, Vol. 21, Núm. 5, pp. 1023-1037

  2. Atrial fibrillation in pigs induces left atrial endocardial transcriptional remodelling

    Thrombosis and Haemostasis, Vol. 108, Núm. 4, pp. 742-749

2011

  1. Adipose-derived stem cells for myocardial infarction

    Journal of Cardiovascular Translational Research, Vol. 4, Núm. 2, pp. 145-153

  2. Adult Stem Cells: From new cell sources to changes in methodology

    Journal of Cardiovascular Translational Research, Vol. 4, Núm. 2, pp. 154-160

2010

  1. Cardiac resynchronization therapy-induced left ventricular reverse remodelling is associated with reduced plasma annexin A5

    Cardiovascular Research, Vol. 88, Núm. 2, pp. 304-313

  2. Repeated implantation of skeletal myoblast in a swine model of chronic myocardial infarction

    European Heart Journal, Vol. 31, Núm. 8, pp. 1013-1021